New Alzheimer’s Drugs May Benefit Whites More Than Blacks
New Alzheimer’s drugs may benefit whites more than black Americans, leading Alzheimer’s experts told Reuters. Leqembi and donanemab are the first Alzheimer’s drugs to offer real hope of slowing cognitive …
New Alzheimer’s Drugs May Benefit Whites More Than Blacks Read More »